Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Ovarian Cancer Clinical Trials in Dallas | 245 Studies

Clinical Trials Ovarian CancerDallas

Ovarian Cancer Clinical Trials in Dallas

Find 245 clinical trials for ovarian cancer near Dallas, Texas. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 245 trials

TerminatedCorrelation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube CancerChemoresponse assays (lab test) measure the effect that chemotherapy treatment has on a patient's cancer cells in the lab.NCT00288275·Irvine, California and 35 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedDocetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004037·Birmingham, Alabama and 66 others

CompletedStudy of AMG 650 in Adult Participants With Advanced Solid TumorsTo evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).NCT04293094·Los Angeles, California and 21 others

TerminatedVeliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerThe primary objective of the study was to evaluate whether progression-free survival (PFS) was prolonged with the addition of veliparib to standard platinum-based chemotherapy…NCT02470585·Birmingham, Alabama and 209 others

CompletedEfficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)The purpose of this study is to determine the safety and efficacy of combination therapy with pembrolizumab (MK-3475) and lenvatinib (E7080/MK-7902) in participants with triple…NCT03797326·Duarte, California and 87 others

RecruitingStudy of STP938 (Dencatistat) in Advanced Solid TumoursThe Phase 1a part of the study is a dose escalation of STP938 as a monotherapy. The Phase 1b part of the study is a safety expansion cohort of STP938 as a monotherapy.NCT06297525·St. Petersburg, Florida and 6 others

Active not recruitingA Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionThe purpose of this study is to evaluate the incidence rate and severity of prespecified mirvetuximab soravtansine (MIRV)-related ocular treatment-emergent adverse events (TEAEs)…NCT06365853·Los Angeles, California and 40 others

CompletedQuality of Life in Survivors of Gynecologic CancerRATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for…NCT00003795·Birmingham, Alabama and 43 others

UnknownMonoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and ChemotherapyRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00003634·Berkeley, California and 45 others

CompletedTirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00020696·Birmingham, Alabama and 53 others

CompletedBevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the OvaryThis phase II trial studies how well bevacizumab works in treating patients with sex cord-stromal tumors of the ovary that have come back.NCT00748657·Los Angeles, California and 35 others

TerminatedEfficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First RelapseThis research is being done to find out if Carboplatin and Taxane works better alone or when given with an experimental drug called MORAb-003(farletuzumab) in subjects with first…NCT00849667·Birmingham, Alabama and 374 others

CompletedA Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesThis is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies.NCT02498665·Denver, Colorado and 7 others

CompletedNivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase II trial studies how well nivolumab works with or without ipilimumab in treating patients with epithelial ovarian, primary peritoneal, or fallopian tube…NCT02498600·Auburn, California and 200 others

CompletedA Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerThe purpose of this study is to assess the efficacy and safety of trabectedin+DOXIL as a third-line chemotherapy regimen (treatment) in patients with platinum-sensitive…NCT01846611·Birmingham, Alabama and 137 others

UnknownIntravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid TumorsA Phase 1/2a Open-Label Dose Escalation and Dose Expansion Study of T3011 when Administered Intravenously as a Single Agent and in Combination with Other Therapy in Subjects with…NCT04780217·Phoenix, Arizona and 5 others

CompletedPhase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerImmunotherapy is a novel way to treat cancer and does so by targeting the immune system to destroy tumor cells.NCT01416038·Buffalo, New York and 6 others

CompletedSafety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous TherapiesThe purpose of this study is to determine the safety profile, including the maximum tolerated dose (MTD), of ATI-1123 a liposomal formulation of docetaxel, in the treatment of…NCT01041235·Dallas, Texas and 1 other

RecruitingA Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer.NCT06161025·Anchorage, Alaska and 163 others

RecruitingA Study of LY4337713 in Participants With FAP-Positive Solid TumorsThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread.NCT07213791·Newport Beach, California and 29 others

PreviousPage 5 of 13Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia